High Zn content of Randall's plaque: A μ-X-ray fluorescence investigation

Journal of Trace Elements in Medicine and Biology

Volumn 25, Issue 3, 2011, Pages 160-165

  Carpentier, Xavier ^a,b,e   Bazin, Dominique ^a,e   Combes, Christelle ^a,e   Mazouyes, Aurélie ^a,e   Rouzière, Stephan ^a,e   Albouy, Pierre Antoine ^a,e   Foy, Eddy ^c,e   Daudon, Michel ^d,e  

^a UNIVERSITÉ PARIS SUD   (France)

^b PASTEUR HOSPITAL   (France)

^c CNRS   (France)

^d CEA SACLAY   (France)

^e HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

X ray diffraction; X ray fluorescence; Kidney stone; Oligoelements; Randall's plaque

Indexed keywords

CARBAPATITE; TRACE ELEMENT; UNCLASSIFIED DRUG; ZINC;

ARTICLE; CHEMICAL ANALYSIS; CHEMICAL COMPOSITION; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; HUMAN TISSUE; INFRARED SPECTROSCOPY; KIDNEY CALCIFICATION; KIDNEY DISEASE; KIDNEY MEDULLA; MU X RAY DIFFRACTION; MU X RAY FLUORESCENCE; NEPHROLITHIASIS; PATHOGENESIS; PRIORITY JOURNAL; RANDALL PLAQUE; TISSUE REACTION; X RAY DIFFRACTION; X RAY FLUORESCENCE;

CALIBRATION; HUMANS; KIDNEY CALCULI; LEAD; SPECTROMETRY, X-RAY EMISSION; STRONTIUM; X-RAY DIFFRACTION; ZINC;

EID: 80052727520     PISSN: 0946672X     EISSN: 18783252     Source Type: Journal    
DOI: 10.1016/j.jtemb.2011.05.004     Document Type: Article

References (56)

1. Randall A. An hypothesis for the origin of renal calculus. N Eng J Med 1936, 111:1006-1011.
2. Daudon M., Traxer O., Jungers P., Bazin D. Stone morphology suggestive of Randall's plaque. Renal stone disease, AIP conference proceedings, vol. 900 2007, 26-32.
3. Low R.K., Stoller M.L. Endoscopic mapping of renal papillae for Randall's plaques in patients with urinary stone disease. J Urol 1997, 158:2062-2064.
4. Matlaga B.R., Coe F.L., Evan A.P., Lingeman J.E. The role of Randall's plaques in the pathogenesis of calcium stones. J Urol 2007, 177:31-38.
5. Kim S.C., Coe S.L., Tinmouth W., et al. Stone formation is proportional to papillary surface coverage by Randall's plaque. J Urol 2005, 173:117-123.
6. Hesse A., Brandle E., Wilbert D., Kohrmann K.U., Alken P. Study on the prevalence and incidence of urolithiasis in Germany comparing the years 1979 vs. 2000. Eur Urol 2003, 44:709-713.
7. Yoshida O., Terai A., Ohkawa T., Okada Y. National trend of the incidence of urolithiasis in Japan from 1965 to 1995. Kidney Int 1999, 56:1899-1904.
8. Trinchieri A., Coppi F., Montanari E., Del Nero A., Zanetti G., Pisani E. Increase in the prevalence of symptomatic upper urinary tract stones during the last ten years. Eur Urol 2000, 37:23-35.
9. Stamatelou K.K., Francis M.E., Jones C.A., Nyberg L.M., Curhan G.C. Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int 2003, 63:1817-1823.
10. Cifuentes Delatte L., Miñon Cifuentes J.L., Medina J.A. New studies on papillary calculi. J Urol 1987, 137:1024-1029.
11. Evan A.P., Lingeman J.E., Coe F.L., et al. Randall's plaque of patients with nephrolithiasis begins in basement membrane of thin loops of Henle. J Clin Invest 2003, 111:607-616.
12. Evan A.P., Coe F.L., Lingeman J.E., et al. Mechanism of formation of human calcium oxalate renal stones on Randall's plaque. Anat Rec (Hoboken) 2007, 290:1315-1323.
13. Daudon M, Traxer O, Williams JC Jr, Bazin D. Randall's plaques, in: Rao Nagaraja P, Preminger GM, Kavanagh JP, editors. In Urinary Tract Stone Disease, Berlin, Springer, SBN 978-1-84800-361-3.
14. Oka T., Yoshioka T., Koide T., Takaha M., Sonoda T. Role of magnesium in the growth of calcium oxalate monohydrate crystals. Urol Int 1987, 42:89-95.
15. Gupta A., Srivastava D.K., Kumar S. Role of zinc in nephrolithiasis. J Ind Med Assoc 1984, 82:235-237.
16. Sutor D.J. Growth studies of calcium oxalate in the presence of various ions and compounds. Br J Urol 1969, 41:171-185.
17. Grases F., Genestar C., Mill A. The influence of some metallic ions and their complexes on the kinetics of crystal growth of calcium oxalate. J Cryst Growth 1989, 94:507-517.
18. Meyer J.L., Thomas W.C. Trace metal-citric acid complexes as inhibitors of calcification and crystal growth. II. Effects of Fe(III), Cr(III) and Al(III) complexes on calcium oxalate crystal growth. J Urol 1982, 128:1376-1385.
19. Pindea-Vargas C.A., Eise M.E.M., Rodgers A.L. Characterization of human kidney stones using micro-PIXE and RBS: a comparative study between two different populations. Appl. Radiat. Isotopes 2009, 67:464-469.
20. Chaudhri M.A., Watling J., Khan F.A. Spatial distribution of major elements and trace elements in bladder and kidney stone. J Radio Nucl Chem 2007, 271:713-720.
21. Rodriguez-Minon Cifuentes J.L., Salvador E., Traba Villameytide M.L. Usual elements in kidney stones. Actas Urol Esp 2006, 30:57-62.
22. Bazin D., Chevallier P., Matzen G., Jungers P., Daudon M. Heavy elements in urinary stones. Urol Res 2007, 35:179-184.
23. Bazin D., Carpentier X., Traxer O., Thiaudière D., Somogyi A., Reguer S., et al. Very first tests on SOLEIL regarding the Zn environment in pathological calcifications made of apatite determined by X-ray absorption spectroscopy. J Syn Rad 2008, 15:506-509.
24. Bazin D., Carpentier X., Brocheriou I., Dorfmuller P., Aubert S., Chappard Ch, et al. Biochimie 2009, 91:1294-1300.
25. Daudon M., Bader C.A., Jungers P. Urinary calculi: review of classification methods and correlations with etiology. Scanning Microsc 1993, 7:1081-1090.
26. Daudon M., Jungers P., Bazin D. Peculiar morphology of stones in primary hyperoxaluria. N Eng J Med 2008, 359:100.
27. Bazin D., Daudon M., Chevallier P., Rouzière S., Elkaim E., Thiaudière D., et al. Les techniques de rayonnement synchrotron au service de la caractérisation d'objets biologiques: un exemple d'application, les calculs rénaux. Ann de Biol Clin 2006, 64:125-139.
28. Estepa L., Daudon M. Contribution of F.T. infrared spectroscopy to the identification of urinary stones and kidney crystal deposits. Biospectroscopy 1997, 3:347-355.
29. Chougnet A., Heitz C., Sondergard E., Berquier J.M., Albouy P.A., Klotz M. Substrates do influence the ordering of mesoporous thin films. J Mater Chem 2005, 15:3340.
30. Solé V.A., Papillon E., Cotte M., Walter Ph, Susini J. A multiplatform code for the analysis of energy-dispersive X-ray fluorescence spectra. Spectrochim Acta Part B 2007, 62:63-68.
31. Giachelli C.M. Ectopic calcification, gathering hard facts about soft tissue mineralization. Am J Pathol 1999, 154:671-675.
32. Vallet-Regi{dotless} M., Gonzalez-Calbet J.M. Calcium phosphates as substitution of bone tissues. Progr Sol St Chem 2004, 32:1-31.
33. Drouet C., Bosc F., Banu M., Largeot C., Combes Ch, Dechambre G., et al. Nanocrystalline apatites: from powders to biomaterials. Powder Technol 2009, 190:118-122.
34. Farquharson M.J., Al-Ebraheem A., Falkenberg G., Leek R., Harris A.L., Bradley D.A. The distribution of trace elements Ca, Fe, Cu and Zn and the determination of copper oxidation state in breast tumour tissue using SRXRF and XANES. Phys Med Biol 2008, 53:3023-3030.
35. Zelentsov E.L., Moroz T.N., Kolmogorov Y.P., Tolmachev V.E., Dragun G.E., Palchik N.A., et al. The elemental SRXRF analysis and mineral composition of human salivary stones. NIM A 2001, 470:417-421.
36. Ekinci N., Sahin Y. Determination of calcium and iodine in gall bladder stone using energy dispersive X-ray fluorescence spectrometry. Spectrochim Acta B 2002, 57:167-171.
37. Vezzoli G., Caumo A., Baragetti I., Zerbi S., Belinzoni P., Centemero A., et al. Study of calcium metabolism in idiopathic hypercalciuria by strontium oral load test. Clin Chem 1999, 45:257-261.
38. Komaromy-Hiller G., Owen Ash K., Costa R., Howerton K. Comparison of representative ranges based on U.S. patient population and literature reference intervals for urinary trace elements. Clin Chim Acta 2000, 296:71-90.
39. Caroli S., Alimonti A., Coni E., Petrucci F., Senofonte O., Violante N. Occupational exposure of goldsmith workers of the area of Rome to potentially toxic metals as monitored through hair analysis. Crit Rev Anal Chem 1994, 24:363-398.
40. Bigi A., Falini G., Foresti E., Gazzano M., Ripamonti A., Roveri N. Rietveld structure refinements of calcium hydroxyapatite containing magnesium. Acta Cryst B 1996, 52:87-92.
41. Rokita E., Hermes C., Nolting H.F., Ryczek J. Substitution of calcium by Sr within selected calcium phosphates. J Cryst Growth 1993, 130:543-552.
42. Sugiyama S., Moriga T., Hayashi H., Moffat J.B. Characterization of Ca, Sr, Ba and Pb HAP: X-ray diffraction, photoelectron. Exafs and MAS NMR spectroscopies. Bull Chem Soc Jpn 2001, 74:187-192.
43. Li M., Xiao X., Rongfang L., Chen C., Huang L. Structural characterization of zinc-substituted hydroxyapatite prepared by hydrothermal method. J Mater Sci: Mater Med 2008, 19:797-803.
44. Fujii E., Ohkubo M., Tsuru K., Hayakawa S., Osaka A., Kawabata K., et al. Selective protein adsorption property and characterization of nano-crystalline zinc-containing hydroxyapatite. Acta Biomater 2006, 2:69-74.
45. Ren F., Xin R., Ge X., Leng Y. Characterization and structural analysis of zinc-substituted hydroxyapatites. Acta Biomater 2009, 5:3141-3149.
46. Cuisinier F.J.G., Mayer I., Voegel J.C. Microscopie électronique de haute résolution de carbonato-apatites synthétiques enrichies en zinc et en gallium. In Actualités en Biomatériaux 1993, vol. II:322-326. Romillat, Paris.
47. Mayer I., Apfelbaum F., Featherstone J.D. Zinc ions in synthetic carbonated hydroxyapatites. Arch Oral Biol 1994, 39:87-90.
48. Chapell H., Shepherd D., Best S. Zinc substituted hydroxyapatite - a comparison of modelling and experimental data. Key Eng Mater 2009, 396-398:729-732.
49. Tang Y., Chapell H., Dove M.T., Reeder R.J., Lee Y.J. Zinc incorporation into hydroxylapatite. Biomaterials 2009, 30:2864-2872.
50. Wu L.N.Y., Genge B.R., Wuthier R.E. Differential effects of zinc and magnesium ions on mineralization activity of phosphatidylserine calcium phosphate complexes. J Inorg Biochem 2009, 103:948-962.
51. Legeros R.Z., Bleiwas C.B., Retino M., Rohanizadeh R., Legeros J.P. Zinc effect on the in vitro formation of calcium phosphates: relevance to clinical inhibition of calculus formation. Am J Dent 1999, 12:65-71.
52. Legeros R.Z., Mijares D., Park J., Chang X.F., Khairoun I., Kijkowska R., et al. Amorphous calcium phosphates (ACP): formation and stability. Key Eng Mater 2005, 284-286:7-10.
53. Bao B., Prasad A.S., Beck F.W., et al. Zinc supplementation decreases oxidative stress, incidence of infection, and generation of inflammatory cytokines in sickle cell disease patients. Transl Res 2008, 152:67-80.
54. Besecker B., Bao S., Bohacova B., Papp A., Sadee W., Knoell D.L. The human zinc transporter SLC39A8 (Zip8) is critical in zinc-mediated cytoprotection in lung epithelia. Am J Physiol Lung Cell Mol Physiol 2008, 294:L1127-L1136.
55. Haase H., Ober-Blobaum J.L., Engelhardt G., et al. Zinc signals are essential for lipopolysaccharide-induced signal transduction in monocytes. J Immunol 2008, 181:6491-6502.
56. Carpentier X., Bazin D., Jungers P., Reguer S., Thiaudière D., Daudon M. The pathogenesis of Randall's plaque: a papilla cartography of Ca compounds through an ex vivo investigation based on a synchrotron radiation related technique. J Synchrotron Rad 2010, 17:374-379.